Trials / Recruiting
RecruitingNCT05356611
Engage for Late-Life Depression and Comorbid Executive Dysfunction
Engage: A Treatment for Late-Life Depression and Comorbid Executive/Cognitive Dysfunction
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- University of Nevada, Las Vegas · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
Although there are an increasing number of mental health treatment adaptations for older adults, there are still a number of factors to consider when making these adaptations. Cognitive decline is one such factor that places significant burden on older adults and can interfere with traditional mental health therapies. Engage is a behavioral treatment approach that has shown to be effective in treating late life depression. The investigators are testing the feasibility of Engage as a treatment method for late life depression in older adults with cognitive decline. The objective is to corroborate Engage as an alternative late life depression treatment method for a sub-population of older adults with cognitive decline. Cognitive decline poses a unique mental health treatment barrier that is often over looked in younger populations. With a relatively higher prevalence of cognitive decline in older adulthood, it is imperative that a feasible mental health treatment program that can be effective in the presence of cognitive decline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Engage | Engage is a 9-week, behavioral-based, psychotherapy treatment protocol for late-life depression. |
Timeline
- Start date
- 2023-09-24
- Primary completion
- 2024-12-01
- Completion
- 2025-05-01
- First posted
- 2022-05-02
- Last updated
- 2024-08-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05356611. Inclusion in this directory is not an endorsement.